AstraZeneca Boosts Cancer Portfolio With $320 Million Neogene Deal ...Middle East

AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca Boosts Cancer Portfolio With $320 Million Neogene Deal )

Also on site :

• Israeli embassy worker couple shot dead outside Jewish museum in Washington DC by gunman chanting ‘Free Palestine’
• Suspect in shooting that killed 2 Israeli embassy staffers chanted ‘free, free Palestine’ after arrest: DC police chief
• Which Tiny “Purse” Dog Breed Are You, Based on Your Zodiac Sign